Lapsed Aug 23, 2024 on the fee record · High confidence
20-year base term ended Mar 13, 2026
Second maintenance fee unpaid; grace period ended.
Held by Neuropace, Inc.
Filed Jul 9, 2015 as application 14/795,741 · Granted Aug 23, 2016
Base term, 20 years from filing
Today
Lapsed Aug 23, 2024
2006
2026
Clock starts
Mar 13, 2006
Mar 13, 2006
No longer in force
Aug 23, 2024
Aug 23, 2024
Granted
Aug 23, 2016
Aug 23, 2016
Term would have run to
Mar 13, 2026
Mar 13, 2026
base term
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,114,260, to Mar 13, 2026. The term already ends on or before that date, so the cap shortened nothing.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Mar 13, 2026: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 13, 2006, when application 11/374,380, the earliest non-provisional in its chain, was filed (this one was filed Jul 9, 2015) | Mar 13, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,114,260) | resolves to Mar 13, 2026, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | lapsed Aug 23, 2024 | High confidence |
| Computed term end | The steps above, in order | Aug 23, 2024 | High confidence |
This family
| US 7,894,905 | In force Sep 2029 | Sep 2029 |
| US 8,583,239 | Lapsed on the fee record Nov 2025 | Nov 2025 |
| US 8,805,520 | Term ended Mar 2026 | Mar 2026 |
| US 9,114,260 | Term ended Mar 2026 | Mar 2026 |
| US 9,421,371 | this patent Aug 2024 | Aug 2024 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 13, 2016 Reel 39148, frame 911 | Pless, Benjamin D.; John, Michael Sasha | Neuropace, Inc. | Assignment of Assignor's Interest |
| Apr 4, 2019 Reel 49466, frame 517 | Neuropace, Inc. | CRG Servicing LLC | Security Interest |
| Sep 25, 2020 Reel 53885, frame 932 | Neuropace, Inc. | CRG Servicing LLC | Security Interest |
| Jun 4, 2025 Reel 71495, frame 800 | CRG Servicing LLC as Successor to Capital Royalty Partners II L.P., Capital Royalty Partners II - Parallel Fund "a" L.P., and Parallel Investment Opportunities Partners II L.P. | Neuropace Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,114,260, ends no earlier than this term, so it caps nothing.
Citations
61
later US patents cite this one
That is top 10% of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.